Savara Pharmaceuticals plans to expand its pipeline of orphan respiratory drugs by acquiring Serendex Pharmaceuticals, a provider of inhalation therapies for rare respiratory conditions.

Pursuant to the transaction, Savara Pharma will acquire all of Serendex Pharma’s assets to add up to two new programmes in its pipeline.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Xiangxue Pharmaceuticals has announced that it will acquire a 60% stake in a Guangzhou-based biotechnology company.

Xiangxue Pharmaceuticals plans to acquire the company through stake acquisition and in the form of cash or equity.

Pharmaceutical Technology Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Pharmaceutical Technology Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now